Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 4

1(12.5%)

Phase 2

1(12.5%)

8Total

N/A(6)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06105892Not ApplicableRecruiting

Eye Recovery Automation for Post Injury Dysfunction (iRAPID)

Role: collaborator

NCT07484906Phase 2Withdrawn

Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

Role: collaborator

NCT05236010Not ApplicableRecruiting

Control Network Neuromodulation to Enhance Cognitive Training in Complex Traumatic Brain Injury

Role: collaborator

NCT06449326Not ApplicableRecruiting

Multimodal Image Analysis and Guidance of Neuromodulation for Trauma-Related Symptoms

Role: collaborator

NCT03343028Completed

Biomarker Establishment for Superior Treatment of PTSD

Role: collaborator

NCT02069873Not ApplicableCompleted

Effectiveness of Cognitive, Exposure, and Skills Group Manualized Treatments in Operations Iraqi (OIF)/Operation Enduring Freedom (OEF) Female Veterans

Role: lead

NCT00824694Not ApplicableCompleted

Impact of Accu-Chek 360 in Veterans With Type 2 Diabetes

Role: collaborator

NCT00567099Not ApplicableUnknown

Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole

Role: lead

NCT00224822Phase 4Completed

The Effects of Aripiprazole on Patients With Metabolic Syndrome

Role: lead

NCT00536783Completed

Schizophrenia Sensory Gating Deficit With Quetiapine

Role: lead

All 10 trials loaded